CIK: 0001358331 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 15, 2022
Total Value ($000): $363,879 (94.0% shares, 6.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UHAL | Amerco | 75,455 | $38,423 | 10.6% | $21.49 | +143.8% | Common | 023586100 |
| ABBV | Abbvie | 223,500 | $29,995 | 8.2% | $47.22 | +169.2% | Common | 00287Y109 |
| ALL | Allstate | 229,300 | $28,554 | 7.8% | $46.67 | +145.6% | Common | 020002101 |
| — | Merck | 323,700 | $27,877 | 7.7% | $47.97 | — | Common | 589331107 |
| — | Nextera Energy | 350,000 | $27,443 | 7.5% | $80.80 | — | Common | 302571104 |
| CMS | CMS Energy | 418,500 | $24,373 | 6.7% | $25.17 | +140.2% | Common | 125896100 |
| DUK | Duke Energy | 261,200 | $24,296 | 6.7% | $47.24 | +99.0% | Common | 26441C204 |
| XEL | XEL Energy | 372,500 | $23,840 | 6.6% | $24.91 | +160.3% | Common | 98389B100 |
| PFE | Pfizer | 542,700 | $23,748 | 6.5% | $18.94 | +113.4% | Common | 717081103 |
| T | AT & T | 1,072,000 | $16,444 | 4.5% | $14.93 | +1.0% | Common | 00206R102 |
| ABT | Abbott | 167,600 | $16,216 | 4.5% | $33.85 | +195.4% | Common | 002824100 |
| — | Paratek | 16,600,000 | $14,774 | 4.1% | $0.89 | — | Cv 4.75% | 699374AA2 |
| AAPL | Apple | 66,000 | $9,121 | 2.5% | $86.19 | +79.0% | Common | 037833100 |
| AVA | Avista | 205,000 | $7,595 | 2.1% | $21.15 | +67.4% | Common | 05379B107 |
| IIIN | Insteel | 274,000 | $7,269 | 2.0% | $24.89 | 0.0% | Common | 45774W108 |
| — | Bausch Health | 931,000 | $6,414 | 1.8% | $18.84 | — | Common | 91911K102 |
| EDAP | EDAP | 565,652 | $4,666 | 1.3% | $2.73 | — | Common | 268311107 |
| SUPN | Supernus | 122,105 | $4,133 | 1.1% | $28.47 | +14.3% | Common | 868459108 |
| — | Paratek | 1,557,312 | $4,002 | 1.1% | $4.84 | — | Common | 699374302 |
| — | XM Sirius | 657,843 | $3,756 | 1.0% | $3.50 | — | Common | 82968B103 |
| — | Acorda Theraputics | 5,000,000 | $3,700 | 1.0% | $0.83 | — | Cv 6.0% | 00484MAB2 |
| NEM | Newmont | 65,000 | $2,731 | 0.8% | $27.95 | +50.9% | Common | 651639106 |
| — | Accelerate Diagnostic | 3,000,000 | $2,700 | 0.7% | $0.66 | — | Cv 2.5% | 00430HAB8 |
| — | Ashland | 25,000 | $2,374 | 0.7% | $97.00 | — | Common | 044209104 |
| — | Amryt | 315,182 | $2,181 | 0.6% | $12.09 | — | Common | 03217L106 |
| WBD | Warner Bros. Discovery | 122,558 | $1,409 | 0.4% | $18.55 | -26.7% | Common | 934423104 |
| FATE | Fate Theraputics | 57,000 | $1,277 | 0.4% | $22.84 | +26.5% | Common | 31189P102 |
| — | IGM Bioscience | 55,000 | $1,250 | 0.3% | $83.20 | — | Common | 449585108 |
| OGN | Organon | 31,970 | $748 | 0.2% | $26.28 | -2.4% | Common | 68622V106 |
| — | GE | 10,000 | $619 | 0.2% | $10.02 | — | Common | 369604103 |
| MNKD | Mannkind | 195,073 | $602 | 0.2% | $4.01 | -5.9% | Common | 56400P706 |
| — | Novavax | 600,000 | $580 | 0.2% | $0.61 | — | Cv 3.75% | 670002AB0 |
| VTRS | Viatris | 61,512 | $524 | 0.1% | $11.72 | -28.1% | Common | 92556V106 |
| RLI | RLI | 2,400 | $245 | 0.1% | $12.47 | +285.0% | Common | 749607107 |